Phytabolites, an aggressive IPR based company, has provided new global platform with a global vision of evolving global or local collaborations at all levels of business development including licensing agreements with collaborators sharing the same global vision.
S. NO. |
Product |
Granted Patent no. |
In-force Patent application no. |
Patent / Application Jurisdiction |
Demographic relevance: Million people |
1 |
Plezzant |
IN 251399 |
|
India |
135 |
2 |
Plezzant |
EP(UK)1796696 |
|
United Kingdom |
7 |
3 |
Plezzant |
EP(FR)1796696 |
|
France |
6.5 |
4 |
Plezzant |
EP(DE)1796696; |
|
Germany |
8.2 |
5 |
Plezzant |
|
11/661397 |
USA |
32.6 |
6 |
Lefiber |
IN 291544 |
|
India |
135 |
7 |
Lefiber |
|
EP2114425 |
EPO |
74 |
8 |
Lefiber |
|
12/448600 |
USA |
32.6 |
9 |
Lefiber |
|
IN 201721040337 |
India. PCT to be filed wide in National Phase |
750 |
10 |
Green 100 |
|
586/MUMNP/2013 |
India |
1350 |
11 |
Green 100 |
|
EP2611311 |
EPO |
740 |
12 |
Green 100 |
|
13/819,903 |
USA; claim on "Green 100" allowed recently for grant |
320 |
13 |
LeImmune |
IN 291544 |
|
India |
1350 |
14 |
LeImmune |
|
EP2114425 |
EPO |
740 |
15 |
LeImmune |
|
12/448600 |
USA |
320 |
16 |
LeImmune |
|
IN 201721040337 |
India. PCT to be filed wide in National Phase |
7500 |
17 |
Adipomimetin |
IN 201621011729 |
India |
405 |
|
18 |
Adipomimetin |
PCT/IN2017/050124 |
PCT to be filed wide in National Phase |
2500 |
|
19 |
Adipomimetin |
IN 201821005029 |
India. PCT application will be filed designated to 145+ countries |
2500 |
|
20 |
CogniActive-Kids |
|
IN 201721036821 |
India. PCT application will be filed designated to 145+ countries |
1900 |
21 |
CogniActive-Kids |
|
IN 201721037389 |
India. PCT application will be filed designated to 145+ countries |
1900 |
22 |
CogniActive-Moms |
|
IN 201721036821 |
India. PCT application will be filed designated to 145+ countries |
3375 |
23 |
CogniActive-Moms |
|
IN 201721037389 |
India. PCT application will be filed designated to 145+ countries |
375 |
24 |
DHA Syrup for hyperactive children |
|
2615/MUM/2015 |
India |
47.25 |
25 |
Urophyll |
|
AP/P/2017/010065 |
ARIPO. Botswana, The Gambia, Ghana, Kenya, Lesotho, Malawi, Mozambique, Namibia, Sierra Leone, Liberia, Rwanda, São Tomé and Príncipe, Somalia, Sudan, Swaziland, Tanzania, Uganda, Zambia and Zimbabwe. |
34.5 |
26 |
Urophyll |
|
2016210540 |
Australia |
2.4 |
27 |
Urophyll |
|
BR 11 2017 015338 6 |
Brazil |
21.1 |
28 |
Urophyll |
|
201680006322.4 |
China |
138.8 |
29 |
Urophyll |
|
201727022163 |
India |
134.2 |
30 |
Urophyll |
|
16739893.2 |
European Patent Organization (EPO). Albania, Austria, Belgium, Bulgaria, Switzerland, Cyprus, Czech Republc, Germany, Denmark, Estonia, Spain, Finland, France, United Kingdom, Grrece, Croatia, Hungary, Iceland, Italy, Liechtenstein , Lithuania, Luxembourg , Latvia, Monaco, Former Yugoslav Republic of Macedonia, Malta, Nethrlands, Norway, Portugal, Poland, Romania, SErbia, Swden, Slovakia, San Marino, Turkey |
58.8 |
31 |
Urophyll |
|
201791319 |
Eurasea (Countries of Earstwhile Soviet Union) Eurasian Patent Office) Turkmenistan, Republic of Belarus,Republic of Tajikistan |
26.3 |
32 |
Urophyll |
|
. 2017-539029 |
Japan |
12.6 |
33 |
Urophyll |
|
11201705694V |
Singapore |
0.57 |
34 |
Urophyll |
|
2017/04804 |
South Africa |
5.5 |
35 |
Urophyll |
|
P6000884/2017 |
United Arab Emirates. Abu Dhabi (which serves as the capital), Ajman, Dubai, Fujairah, Ras al-Khaimah, Sharjah and Umm al-Quwain |
0.9 |
36 |
Urophyll |
|
15/543,966 |
USA |
32.6 |
Proposals for strategic collaboration are invited from interested parties for production, marketing or licensing for the patented and patent applied technology and products.